TD Cowen lowered the firm’s price target on Universal Health (UHS) to $275 from $283 and keeps a Buy rating on the shares. The firm updated its model following Q3 results.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on UHS:
- Universal Health price target lowered to $211 from $222 at RBC Capital
- Universal Health price target raised to $271 from $256 at Barclays
- Closing Bell Movers: Deckers up 12% after earnings beat
- UHS Earnings: Universal Health Services Sinks amid EPS Miss
- Universal Health reports Q3 adjusted EPS $3.71, consensus $3.70